Get startedLog in
    Picture of Daesung Microbiological Labs Co logo

    036480 — Daesung Microbiological Labs Co Income Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Daesung Microbiological Labs Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsARSAnnual Audited AccountsAnnual Audited AccountsARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue24,80123,99725,50025,56223,804
    Cost of Revenue
    Gross Profit8,0415,7384,7944,8494,052
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses22,88323,66025,82826,25125,356
    Operating Profit1,918337-328-689-1,552
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes1,5298432,261-1,082-1,571
    Provision for Income Taxes
    Net Income After Taxes1,5198661,703-680-1,769
    Net Income Before Extraordinary Items
    Net Income1,5198661,703-680-1,769
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income1,5198661,703-680-1,769
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS4682278.24-179-468
    Dividends per Share